Association between treatment‐emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study

Documenti analoghi

• Correction to “Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression”
  Pubblicazione: (2025)
• Efficacy and safety of lenvatinib‐transcatheter arterial chemoembolization sequential therapy for hepatocellular carcinoma within the up‐to‐seven criteria
  di: Shigeo Shimose, et al.
  Pubblicazione: (2025)
• Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein‐1 inhibitors: A promising treatment approach for high‐burden hepatocellular carcinoma
  di: Shumin Fu, et al.
  Pubblicazione: (2024)
• Proteomics for the early diagnosis and treatment of hepatocellular carcinoma
  di: VIJAY KUMAR
  Pubblicazione: (2007)
• Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma
  di: Satoshi Kobayashi, et al.
  Pubblicazione: (2024)